Skip to main content


Loading Presentations

Presentations Search and Views Navigation

Agenda Views Navigation

  • March 24, 2020 at 8:45 AM - 9:45 AM

    Panel Discussion: Women Leaders in Vaccinology

    During this inspiring session, women leaders working in various professional settings will discuss their career paths, successes, and lessons learned while addressing obstacles faced throughout their careers.

    Moderated by Kathleen M. Neuzil, MD, MPH (ACVR Vice Chair; NFID Director; Director, Center for Vaccine Development and Global Health, University of Maryland School of Medicine).

    Read More
  • April 28, 2020 at 12:00 PM - 1:00 PM

    NFID Vaccinology Leadership & Recognition Session

    Robert Austrian Memorial Lecture
    "Episode V: The Pneumococcus Strikes Back"
    Marie R. Griffin, MD, MPH

    Dr. Charles Mérieux Award for Achievement in Vaccinology and Immunology
    Pierce Gardner, MD

    Maurice R. Hilleman Early-Stage Career Investigator Award
    (Recipient to be announced)

    Read More
  • June 18, 2020 at 10:00 AM - 11:15 AM

    Vaccine Development for Novel Coronavirus Response

    The spread of SARS-CoV-2 and the resulting COVID-19 pandemic has had wide-reaching effects that require a multifaceted response. Accelerating vaccine development and distribution is a key component in responding to this emerging pathogen. Vaccine development typically takes decades from research and development to implementation, so having licensed and approved vaccines available for mass distribution in a 12-18 month timeframe would…

    Read More
  • June 18, 2020 at 11:30 AM - 12:30 PM

    Mary Lou Clements-Mann Memorial Lecture in Vaccine Sciences

    Opening Session: Now presented each year at the Annual Conference on Vaccinology Research, the Mary Lou Clements-Mann Memorial Lecture in Vaccine Sciences was initiated by NFID in 1999 to honor and remember a prolific, compassionate, and courageous vaccinologist.

    Read More
  • June 18, 2020 at 12:30 PM - 1:45 PM

    Approaches to Demonstrate Vaccine Effectiveness

    It is getting more difficult for some vaccines to be licensed on the basis of traditional randomized controlled trial demonstrations of efficacy against disease. This session will cover the latest thinking about clinical trial designs and approaches to demonstrate vaccine effectiveness to support licensure (including use of biomarkers predictive of protection, human challenge studies, and real world evidence).

    Read More
  • June 18, 2020 at 2:00 PM - 2:45 PM

    Vaccinomics and Individualized Vaccinology

    Vaccines were traditionally designed to mimic host immunity to infections. Increasingly, vaccines are needed that improve upon natural immunity. This session will highlight a more rational approach—inclusive of systems biology and "-omics" research—to the design and evaluation of the next generation of vaccines. Join us for this exciting panel discussion around the future of vaccinology.

    Read More
  • June 18, 2020 at 3:45 PM - 5:00 PM

    Vaccines for Target Populations

    Concurrent Session

    New vaccines are being developed in special populations that propose novel challenges such as immune suppression, pregnancy, and age. This session will explore approaches to solicit immune responses to vaccination in certain target populations.

    Read More
  • June 19, 2020 at 11:30 AM - 12:30 PM

    Advanced Technologies in Vaccine Manufacturing

    Concurrent Session

    New technologies are being developed and are applied to the production of vaccines. This session will review the application of single cell analysis, next generation sequencing, and continuous manufacturing systems to the development of preventive vaccines.

    Read More
  • June 19, 2020 at 12:30 PM - 1:45 PM

    Partnering to Discover, Develop, and Deliver Vaccines for Global Health

    The late stage development of vaccines for global health use are challenged by complex and costly clinical studies in low-income settings and unclear financial markets. This session will describe the development strategies and partnerships that support the development of malaria, typhoid, and rotavirus vaccines.

    Read More
  • June 19, 2020 at 2:00 PM - 3:00 PM

    Measles Resurgence and Response

    A number of factors including a decline in vaccination in some populations has led to resurgence of measles in the US and globally. This session will review key precipitating factors and response tactics including an examination of the recent New York City outbreak.

    Read More
  • June 19, 2020 at 3:30 PM - 4:45 PM

    Controlling Vaccine-Preventable Diseases: From Elimination to Eradication

    Closing Session

    Widespread vaccination efforts have led to the elimination of infectious diseases such as polio and measles in certain regions. However, eradication requires sustained and adaptable efforts to interrupt transmission in all populations and ensure pathogens are not reintroduced. To date, only one infectious disease that affects humans has been eradicated—smallpox. This session will explore various strategies used to control vaccine-preventable diseases, with the goal of elimination and, ultimately, eradication.

    Read More
+ Export Events